Frazier Financial Advisors, LLC Bio N Tech Se Transaction History
Frazier Financial Advisors, LLC
- $126 Billion
- Q4 2024
A detailed history of Frazier Financial Advisors, LLC transactions in Bio N Tech Se stock. As of the latest transaction made, Frazier Financial Advisors, LLC holds 262 shares of BNTX stock, worth $31,395. This represents 0.02% of its overall portfolio holdings.
Number of Shares
262
Previous 262
-0.0%
Holding current value
$31,395
Previous $31.1 Million
5.21%
% of portfolio
0.02%
Previous 0.02%
Shares
4 transactions
Others Institutions Holding BNTX
# of Institutions
374Shares Held
40.2MCall Options Held
3.32MPut Options Held
2.26M-
Baillie Gifford & CO8.22MShares$985 Million0.74% of portfolio
-
Flossbach Von Storch Ag Cologne, 2M4.41MShares$528 Million2.03% of portfolio
-
Primecap Management CO Pasadena, CA4.3MShares$515 Million0.39% of portfolio
-
Black Rock Inc. New York, NY1.9MShares$227 Million0.0% of portfolio
-
Temasek Holdings (Private) LTD Singapore, U01.81MShares$217 Million1.03% of portfolio
About BioNTech SE
- Ticker BNTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 242,684,992
- Market Cap $29.1B
- Description
- BioNTech SE, a biotechnology company, develops and commercializes immunotherapies for cancer and other infectious diseases. The company is developing FixVac product candidates, including BNT111, which is in Phase II clinical trial for advance melanoma; BNT112 that is in Phase I/IIa clinical trial for prostate cancer; BNT113, which is in Phase II...